Showing results (2001-2010 of 4,695) with videos related to

Sort By:
Pageof 470
Frontiers in Immunology|June 6, 2020
TNFSF14: LIGHTing the Way for Effective Cancer ImmunotherapyJoseph G Skeate, Mikk E Otsmaa, Ruben Prins, et al.
Angewandte Chemie (Weinheim an Der Bergstrasse, Germany)|April 22, 2020
Substrate-Induced Self-Assembly of Cooperative CatalystsPablo Solís Muñana, Giulio Ragazzon, Julien Dupont, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|September 7, 2006
Antibiotics and steroids for exacerbations of COPD in primary care: compliance with Dutch guidelinesBerendina M Roede, Patrick Je Bindels, Henk J Brouwer, et al.
Anesthesiology|March 31, 2006
Reversal of rocuronium-induced neuromuscular block by the selective relaxant binding agent sugammadex: a dose-finding and safety studyIben F Sorgenfrei, Kathrine Norrild, Per Bo Larsen, et al.
Methods in Molecular Biology (Clifton, N.J.)|July 7, 2019
Sharing Programming Resources Between Bio* ProjectsRaoul J P Bonnal, Andrew Yates, Naohisa Goto, et al.
American Journal of Epidemiology|July 7, 2017
Joint Effects of Age, Period, and Cohort on Conduct Problems Among American Adolescents From 1991 Through 2015Katherine M Keyes, Dahsan S Gary, Jordan Beardslee, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|October 1, 2018
Mental Health screening in cystic fibrosis centres across EuropeJ Abbott, T Havermans, S Jarvholm, et al.
Sexually Transmitted Infections|April 5, 2001
Prevalence and risk factors of HSV-1 and HSV-2 antibodies in European HIV infected womenB H van Benthem, J Spaargaren, J A van Den Hoek, et al.
AIDS (London, England)|November 4, 2000
Pregnancies before and after HIV diagnosis in a european cohort of HIV-infected women. European Study on the Natural History of HIV Infection in WomenB H van Benthem, I de Vincenzi, M C Delmas, et al.
Molecular Endocrinology (Baltimore, Md.)|October 2, 2001
Potentiation of glucose uptake in 3T3-L1 adipocytes by PPAR gamma agonists is maintained in cells expressing a PPAR gamma dominant-negative mutant: evidence for selectivity in the downstream responses to PPAR gamma activationC Nugent, J B Prins, J P Whitehead, et al.
Pageof 470